iRhythm Holdings (IRTC) Liabilities and Shareholders Equity (2015 - 2026)
iRhythm Holdings (IRTC) posted quarterly Liabilities and Shareholders Equity of $1.0 billion for Q1 2026, up 8.67% year-over-year from $926.1 million in Q1 2025, and down 1.34% quarter-over-quarter from $1.0 billion in Q4 2025.
iRhythm Holdings (IRTC) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has reported Liabilities and Shareholders Equity for 12 consecutive years, with $1.0 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 8.67% year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $4.0 billion (up 8.12% YoY), while the FY2025 annual figure was $1.0 billion, up 9.51% from the prior year.
- Liabilities and Shareholders Equity fell to $1.0 billion in Q1 2026 per IRTC's latest filing, from $1.0 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $1.0 billion in Q4 2025 and bottomed at $421.7 million in Q1 2023.
- Historically, Liabilities and Shareholders Equity has averaged $709.3 million across 5 years, with a median of $909.7 million in 2024.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity fell 10.4% — and 2024, when it jumped 115.73%.
- iRhythm Holdings' Liabilities and Shareholders Equity stood at $448.2 million in 2022, then decreased by 3.36% to $433.1 million in 2023, then soared by 115.04% to $931.4 million in 2024, then increased by 9.51% to $1.0 billion in 2025, then slipped by 1.34% to $1.0 billion in 2026.
- Business Quant data shows IRTC's Liabilities and Shareholders Equity at $1.0 billion in Q1 2026, $1.0 billion in Q4 2025, and $995.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 10.74 Bn |
| 10 | iRhythm Holdings | 4.23 Bn | 3.64 Bn | 163.21 Mn | 1.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.09 Bn |
| Mar 31, 2026 | 1.01 Bn |
| Dec 31, 2025 | 1.02 Bn |
| Sep 30, 2025 | 995.21 Mn |
| Jun 30, 2025 | 964.03 Mn |
| Mar 31, 2025 | 926.10 Mn |
| Dec 31, 2024 | 931.45 Mn |
| Sep 30, 2024 | 909.69 Mn |
| Jun 30, 2024 | 919.19 Mn |
| Mar 31, 2024 | 909.76 Mn |
| Dec 31, 2023 | 433.14 Mn |
| Sep 30, 2023 | 439.77 Mn |
| Jun 30, 2023 | 429.49 Mn |
| Mar 31, 2023 | 421.70 Mn |
| Dec 31, 2022 | 448.22 Mn |
| Sep 30, 2022 | 440.39 Mn |
| Jun 30, 2022 | 435.69 Mn |
| Mar 31, 2022 | 428.72 Mn |
| Dec 31, 2021 | 462.97 Mn |
| Sep 30, 2021 | 480.25 Mn |